With time, great strides are being made in the care of cancer sufferers. The longevity and quality of life of these unfortunate individuals continues to improve and the word "cure" is more commonly being heard. In a similar manner, there is also much reason for optimism regarding the future fertility options for patients with cancer as well as for those with other diseases that have a high like...

This paper tests whether the fetal origins hypothesis (Barker 1992), which posits that disparities in the preand peri-natal environment can account for long-term disparities in life expectancy, is applicable to the case of variation in early circumstances due to wantedness. To identify the effects of wantedness on fertility rates and on life expectancy, we exploit over-time variation in the leg...

In many modern societies, the proportion of women who delay childbearing beyond the age of 35 years has increased greatly in recent decades. They are falsely reassured by popular beliefs that advances in new reproductive technologies can compensate for the age-realted decline in fertility, but science cannot beat the biological clock. Age is the single most important determinant of male and fem...

BACKGROUND Cancer treatment can diminish fertility in women and men. The need for fertility preservation is growing as increasing numbers of people survive cancer. Cryostorage of reproductive material to preserve potential for conception for cancer survivors has moved from being experimental to being a part of clinical management of women and men who are diagnosed with cancer in their reproduct...

the aim of the study was to determine the farmer's behavior in adoption of ipm technologies in rice growing fields. a questionnaire was employed as the tool of survey. population of the study consisted of the farmers taking apart in ipm/ffs participant groups in gilan and mazandaran provinces each with 3 years of experience in ipm. from among them, 305 were selected as the research sample....

There are relatively few effective clinical options for preserving female fertility, particularly following aggressive chemotherapy and/or radiotherapy treatment protocols. This document reviews the scientific background, current technology, clinical results and potential future applications of two methods for preserving female fertility—ovarian tissue cryopreservation and oocyte cryopreservati...

BACKGROUND Sperm cryopreservation remains the only clinically feasible option to preserve male fertility. The quality of counselling provided by the treating physicians and the cost of sperm cryopreservation can both influence a patient's decision about whether to preserve sperm. On 5 August 2010, the Quebec government introduced provincial coverage of assisted reproductive technologies, with s...

Given the increases in 5-year cancer survival and recent advances in fertility preserving technologies, an increasing number of women with cancer are presenting for discussion of fertility preserving options. This review will summarize the risk of infertility secondary to cancer treatment, available treatment options for fertility preservation, and techniques to reduce future risks for patients...